3-Drug Combination ART: 1996

Sep 10, 2012

230 likes | 383 Views

Share Presentation

Embed Code

Link

niles

Download Presentation

3-Drug Combination ART: 1996

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

1. 3-Drug Combination ART: 1996

Species Animal Health Act

The Animal Drug Availability Act (ADAA) of 1996 required FDA to address minor species animal drug needs ... drugs for these species zoo animals, pocket pets, lab animals ...

1.57k views • 23 slides

Animal Drug Availability Act (ADAA) of 1996

Animal Drug Availability Act (ADAA) of 1996. Legislative History of ADAA and Import Tolerances Jarilyn Dupont Senior Legislative Counsel Food and Drug Administration January 22, 2002. ADAA: Public Law 104-250 Signed into Law 10/09/96.

641 views • 27 slides

Drug Design / drug discovery

Drug Design / drug discovery. Jerome Baudry Assistant Professor BCMB UT/ORNL Center for Molecular Biophysics. 2 previous incarnations: Research faculty at UIUC Research scientist at Transtech Pharma, Inc. . Drug Design / drug discovery. What’s a drug?

989 views • 26 slides

ADVERSE DRUG REACTIONS

ADVERSE DRUG REACTIONS. DR. SHABANA ALI. Adverse Drug Reactions (ADR). Harm associated with the use of a given medications OR Unwanted or harmful reaction experienced after the administration of a drug or combination of drugs under normal conditions of use.

2.41k views • 22 slides

The Drug War: Methods and Stats

U.S. Drug War Goals. Reduce drug use Stopping use before it starts" (Education and community action)Reduce availability Disrupting the market" (Attacking the economic basis of the drug trade)Treat addicts and drug abusers Healing America's drug users" (Getting treatment resourc

567 views • 29 slides

Introduction to Pharmacology

Drug Naming. Chemical Name - describe chemical structure (rarely seen in medical literature)Code Name - short letter-number combination used for experimental drugsGeneric Name - a name assigned to drug that can be used by anyone (not proprietary)Trade Name - Proprietary name given to the drug by

596 views • 27 slides

Strategies in Designing Clinicals for Fixed-Combination Drugs

Strategies in Designing Clinicals for Fixed-Combination Drugs. Combination Drug Development Conference Barnett International Educational Services San Diego, California March 7, 2005. Michael A. Swit, Esq. Vice President, Life Sciences. Our Objectives Today.

453 views • 29 slides

Impact of transmitted drug resistance on virological and immunological response to intial combination antiretroviral th

Impact of transmitted drug resistance on virological and immunological response to intial combination antiretroviral therapy. EuroCoord (CASCADE, COHERE, EuroSIDA and PENTA) and CHAIN (a pan-European project on HIV Drug resistance) largest database on this topic so far.

267 views • 9 slides

HIV Drug Resistance Training

HIV Drug Resistance Training. Module 1: Introduction to HIV Drug Resistance. Topics. Impact of HIV Drug Resistance Factors that Influence Development of Drug Resistance How to Minimize Drug Resistance How to Respond to Detection of Drug Resistance Drug Resistance Assays. Objectives.

1.18k views • 68 slides

Drug Interactions

Chapter 6. Drug Interactions. Drug-Drug Interactions. Basic mechanisms of drug-drug interactions Clinical significance of drug-drug interactions Minimizing adverse drug-drug interactions. Drug-Drug Interactions. Interactions can occur whenever a patient takes more than one drug.

1.53k views • 22 slides

Drug Stores

Drug Stores. Trevor Yerrick Section 2. The Industry. Drug Stores Well-known, established chains In-store pharmacies Pharmacy Benefit Managers (PBMs) Traditional PBMs Combination – CVS Caremark Relationship. Comparable Firms. Walgreen Co.

262 views • 9 slides

Drug Resistance

Drug Resistance. Mono-resistant TB – resistant to only one drug Poly-resistant TB – resistant to more than one drug but not the combination of isoniazid and rifampicin. Multidrug-resistant TB (MDR-TB ) TB caused by bacteria resistant to at least isoniazid and rifampicin.

346 views • 3 slides

Food and Drug Law September 20 , 2010

Food and Drug Law September 20 , 2010. Ralph F. Hall. Overview. Current events Definitions Labeling Key definitional cases Combination products Food Protected interests Key concepts Adulteration. Nutrilab 713 F2d 335 (7 th Cir. 1983). Nutrilab manufactured a “starch blocker”

995 views • 79 slides

The JNC 7 recommendations for initial or combination drug therapy

The JNC 7 recommendations for initial or combination drug therapy are based on sound scientific evidence. 7 th Joint National Committee Report on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Algorithm for Drug Treatment of Hypertension. Initial Drug Choices.

687 views • 52 slides

U.S. Drug Shortages

U.S. Drug Shortages. CAPT Valerie Jensen U.S.Public Health Service Associate Director, CDER Drug Shortage Program Center for Drug Evaluation & Research U.S. Food & Drug Administration. Overview. U.S. Drug Shortage Trends Reasons for Drug Shortages FDA’s Role View of the Future.

733 views • 27 slides

ABSTRACT

ABSTRACT. Combination therapy is the methode of overcoming the global challenge of drug-resistant malaria. Three models of combination therapy of ethanolic extract 80% sambiloto ( Andrographis paniculata Nees.) and curcumin were evaluated in vivo for

146 views • 1 slides

Arrestees’ Drug Use Trajectories

Arrestees’ Drug Use Trajectories. Using the ADAM Drug Use Calendar to Model Patterns of Illicit Drug Use. Brad Myrstol University of Alaska Anchorage Justice Center. Toward a developmental perspective. The Drug–crime connection. Drug Use – Criminal Behavior.

311 views • 14 slides

Using Drug Ontology to Bridge Clinical Trial Eligibility and Patient Record

Using Drug Ontology to Bridge Clinical Trial Eligibility and Patient Record. Helen Chen July 1, 2008. Drug Class Information in CT #8. monotherapy with metformin , insulin secretagogue , or alpha-glucosidase inhibitors and a low dose combination of all Long term insulin therapy

244 views • 6 slides

The Laws of Linear Combination

The Laws of Linear Combination. James H. Steiger. Goals for this Module. In this module, we cover What is a linear combination? Basic definitions and terminology Key aspects of the behavior of linear combinations The Mean of a linear combination The Variance of a linear combination

605 views • 39 slides

FDA Regulation of Combination Products

A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product.

295 views • 5 slides

ADDERALL: ITS USES AND ABUSES

https://www.blvdcenters.org/adderall-uses-abuses .... Adderall is a combination of two stimulant drugs, amphetamine and dextroamphetamine. Adderall XR is an extended-release form of the drug. The drug acts as a central nervous system stimulant that affects brain and nerve chemicals.

239 views • 12 slides

More Related